Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

POC SARS-CoV-2 Diagnostic PCR Device Comparison to FDA Approved Reference PCR Test

NCT04981769 is registered in ClinicalTrials.gov with Anavasi Diagnostics as lead sponsor.

NCT NCT04981769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04981769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
POC SARS-CoV-2 Diagnostic PCR Device Comparison to FDA Approved Reference PCR Test
Lead sponsor
Anavasi Diagnostics
Phase
Observational
Overall status
Unknown status
Start date
August 2, 2021
Completion date
November 30, 2021
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

covid19